+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Risks of Saccharomyces boulardii-Containing Probiotics for the Prevention of Clostridium difficile Infection in the Elderly



Risks of Saccharomyces boulardii-Containing Probiotics for the Prevention of Clostridium difficile Infection in the Elderly



Gastroenterology 153(5): 1450-1451




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 060212472

Download citation: RISBibTeXText

PMID: 28988917

DOI: 10.1053/j.gastro.2017.04.054


Related references

Saccharomyces boulardii for the prevention of hospital onset Clostridium difficile infection. Journal of Gastrointestinal and Liver Diseases 24(1): 21-24, 2016

Prevention of Clostridium difficile infection with Saccharomyces boulardii: a systematic review. Canadian Journal of Gastroenterology 23(12): 817-821, 2010

Probiotics for Clostridium difficile-associated diarrhea: focus on Lactobacillus rhamnosus GG and Saccharomyces boulardii. Annals of PharmacoTherapy 41(7): 1212-1221, 2007

Prevention of further recurrences of Clostridium difficile colitis with Saccharomyces boulardii. Digestive Diseases and Sciences 35(7): 897-901, 1990

Prevention of Clostridium difficile induced mortality in gnotobiotic mice by Saccharomyces boulardii. Canadian Journal of Microbiology 32(11): 894-896, 1986

Prevention of Clostridium difficile-induced experimental pseudomembranous colitis by Saccharomyces boulardii: a scanning electron microscopic and microbiological study. Journal of General Microbiology 136(6): 1085-1089, 1990

Use of prophylactic Saccharomyces boulardii to prevent Clostridium difficile infection in hospitalized patients: a controlled prospective intervention study. European Journal of Clinical Microbiology and Infectious Diseases 37(8): 1431-1439, 2018

Recurrent Clostridium difficile infection in a patient with selective IgG1 deficiency treated with intravenous immune globulin and Saccharomyces boulardii. Clinical Infectious Diseases 20 Suppl 2: S266-S268, 1995

Clinical Characteristics of Symptomatic Clostridium difficile Infection in Children: Conditions as Infection Risks and Whether Probiotics Is Effective. Pediatric Gastroenterology, Hepatology and Nutrition 17(4): 232-238, 2015

Probiotics and prevention of Clostridium difficile infection. Anaerobe 45: 114-119, 2016

Prevention of Clostridium difficile Infection With Probiotics. Clinical Infectious Diseases 60 Suppl 2: S122-S128, 2016

Probiotics for prevention of Clostridium difficile infection. Current Opinion in Gastroenterology 34(1): 3-10, 2017

Probiotics for Prevention and Treatment of Clostridium difficile Infection. Advances in Experimental Medicine and Biology 1050: 161-176, 2018

Use of probiotics in prevention and treatment of patients with Clostridium difficile infection. Best Practice and Research. Clinical Gastroenterology 30(1): 111-118, 2016

Is primary prevention of Clostridium difficile infection possible with specific probiotics?. International Journal of Infectious Diseases 16(11): E786-E792, 2013